Kemel A. Ghotme, George E. Barreto, Valentina Echeverria, Janneth Gonzalez, Rosa H. Bustos, Magdy Sanchez, Jerzy Leszek, Nagendra Sastry Yarla, Rosa Margarita Gomez, Vadim V. Tarasov, Ghulam Md Ashraf and Gjumrakch Aliev Pages 1438 - 1447 ( 10 )
Gliomas are central nervous system tumors originated from glial cells, whose incidence and mortality is expected to rise in coming years, especially in developing countries. Diagnosis and classification of gliomas have largely relied on tumor histopathologic features that provide limited information regarding response to therapy or prognosis. Current treatment of gliomas is surgery combined with chemotherapy and/or radiotherapy. However, many tumors show a high resistance to these interventions, and recurrences are frequent since conventional therapies do not take into account the unique molecular features of different subtypes of glioma. Molecular genetics provide new insights in classifying gliomas and predicting response to therapy that can range from conventional treatments to new revolutionary therapeutic approaches. This article offers a review of the intracellular signaling pathways involved in carcinogenesis of gliomas, as well as a description of new tools for their diagnosis, prognosis, and treatment with a target-oriented approach.
Biomarkers, Genotype, Glioma, Gliomagenesis, Phenotype, Prognosis, Signaling Pathways, Treatment.
Faculty of Medicine, Universidad de La Sabana, Chia, Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá D.C., Universidad San Sebastian, Lientur, Concepcion, Departamento de Nutricion y Bioquimica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogota D.C., Universidad de la Sabana, Chia, Fundacion de NeuroRegeneracion de Colombia, Bogota, Department of Psychiatry, Wroclaw Medical University, Wroclaw, Department of Biochemistry and Bioinformatics, Institute of Science, GITAM University, Viskhapatnam, A.P., Fundacion de NeuroRegeneracion de Colombia, Bogota, Institute of Pharmacy and Translational Medicine, Sechenov First Moscow State Medical University, 2-4 Bolshaya Pirogovskaya St., 119991 Moscow, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, GALLY International Biomedical Research Consulting LLC., 7733 Louis Pasteur Drive, #330, San Antonio, TX, 78229